Revenue Cycle Insider

Question: Hi, I’m working in an ob-gyn practice, and we recently had a patient receive botulinum toxin (Botox) injections into the pelvic floor muscles to treat high-tone pelvic floor dysfunction and pain. The physician documented injections into multiple pelvic floor muscles but stated this is not a trigger point injection. I’ve seen references suggesting CPT^® codes 52287 (for bladder), 64646 (chemodenervation of trunk muscles), and trigger point injection codes 20552-20553.

I’m confused because if I use 20552/20553 with J0585 for Botox, the claim often gets a denial. If I use 64646 with J0585, it sometimes clears, but the pelvic floor muscles aren’t technically trunk muscles. How should I report these injections correctly? I want to code accurately and avoid denials, but I’m stuck.

Wisconsin Subscriber

Answer: First, it’s important to remember: Coding should reflect the service provided, not whether the payer will reimburse it. Using a code simply because it “clears” claims can create compliance risks. Your coding should align with what the physician documented and what was actually done.

So, the codes you suggested considering are:

Trigger point injection codes (20552-20553):

• 20552 (Injection(s); single or multiple trigger points, 1-2 muscles)
• 20553 (Injection(s); single or multiple trigger points, 3 or more muscles)

These codes are used when the injection targets specific muscles to relieve pain or spasm, which aligns with how Botox is often used in pelvic floor dysfunction.

Chemodenervation codes (64642-64647):

• Includes 64646 (Chemodenervation of trunk muscle(s), 1-5 muscles)
• Intended for Botox or similar toxins injected to paralyze or reduce activity of trunk muscles, typically for conditions like spasticity or movement disorders
• Note: The trunk muscles do not include the pelvic floor muscles

Bladder injection code 52287 (Cystourethroscopy, with injection(s) for chemodenervation of the bladder):

• Specifically for bladder wall injections, not pelvic floor muscles, so this is not appropriate in this scenario.

According to the AHA HCPCS Coding Clinic (Second Quarter 2021, Question 8):

• In cases where Botox is injected into the pelvic floor muscles and documented as trigger point injections, the correct CPT^® code is 20553 (Injection(s); single or multiple trigger point(s), 3 or more muscles) if three or more muscles are injected.
• Even though Botox is a chemodenervation agent, when it is used to relieve pain by targeting muscles, it is considered a trigger point injection.
• You should also report the units of Botox separately using HCPCS Level II code J0585 (Injection, onabotulinumtoxinA, 1 unit).

If documentation is ambiguous, clarify with the provider: Is the goal pain relief (trigger point) or muscle relaxation/spasticity (chemodenervation)? The coding choice depends on intent and documentation, not on what “clears” claims.

Key: Here’s what to remember when coding this scenario:

• Documentation drives the code. If the physician documents “trigger point injections,” you use 20552/20553.
• The number of muscles injected determines whether you report 20552 or 20553.
• The location matters. Pelvic floor muscles are not trunk muscles, so CPT^® code 64646 is technically inaccurate.

In practice, coders often see these scenarios:

• Physician wants to use 64646 for Botox into pelvic floor muscles.
• Facility coding team uses 20552/20553.
• HCPCS code J0585 can flag a denial if paired with 20552/20553 in certain payer systems, because payers often expect 64646 to be reported with Botox.

Here’s what to do to resolve these situations.

First, you need to clarify documentation with the physician. Ask whether the Botox injection was intended to target painful muscle knots (trigger points) or purely for muscle relaxation/chemodenervation. Your coding choice depends on this clarification.

Read the documentation carefully as documentation drives compliance. Your provider should have listed all muscles injected, the number of injection sites per muscle, and the purpose (pain relief versus spasticity reduction). All of this information should be clearly noted.

Also, remember to coordinate with billing. Facility and professional coding must match documentation and payer requirements. Some payers may require 64646 to accept J0585; others accept 20553 with J0585. Some commercial payers may reject 20553 with J0585 because they expect 64646 for Botox. Document your rationale and retain supporting clinical notes in case of audit.

Use the trigger point injection codes when pain relief is the goal. Most ob-gyn and pelvic floor Botox injections are performed to alleviate pain or spasms, which aligns with 20552/20553 coding.

Always report units separately with J0585. Even if 20552/20553 is used, include the total units administered.

Suzanne Burmeister, BA, MPhil, Medical Writer and Editor